XML 112 R97.htm IDEA: XBRL DOCUMENT v3.19.1
13) Stock Compensation Plans: Schedule of Activity of Stock Option Plans (Tables)
12 Months Ended
Dec. 31, 2018
Tables/Schedules  
Schedule of Activity of Stock Option Plans

 

 

 

Number of Class A Shares

 

Weighted Average Exercise Price

 

Number of Class C Shares

 

Weighted Average Exercise Price

Outstanding at December 31, 2016

 

      741,973

 

$    4.33

 

      556,298

 

$    4.52

Adjustment for the effect of stock dividends

 

       40,978

 

 

 

       24,934

 

 

Granted

 

      124,500

 

 

 

       70,000

 

 

Exercised

 

        (8,182)

 

 

 

    (103,402)

 

 

Cancelled

 

      (18,843)

 

 

 

      (24,227)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

      880,426

 

$    4.35

 

      523,603

 

$    5.24

Adjustment for the effect of stock dividends

 

       48,168

 

 

 

       27,491

 

 

Granted

 

      142,000

 

 

 

       90,000

 

 

Exercised

 

      (42,211)

 

 

 

                -

 

 

Cancelled

 

      (17,109)

 

 

 

      (63,814)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

   1,011,274

 

$    4.49

 

      577,280

 

$    5.15

 

 

 

 

 

 

 

 

 

Exercisable at end of year

 

 

      862,174

 

$    4.31

 

      482,780

 

$    5.13

 

 

 

 

 

 

 

 

 

Available options for future grant

 

      297,128

 

 

 

      146,425

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

outstanding at December 31, 2018

 

6.14 years

 

 

 

3.96 years

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

exercisable at December 31, 2018

 

5.90 years

 

 

 

2.80 years

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options outstanding

 

 

 

 

 

 

 

at December 31, 2018 (1)

 

$792,135

 

 

 

$188,462

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options exercisable

 

 

 

 

 

 

 

at December 31, 2018 (1)

 

$792,135

 

 

 

$188,462

 

 

                   

 

 

 

 

 

 

 

 

(1) The Company used a stock price of $4.91 as of December 31, 2018 to derive intrinsic value.